Stay updated on Bemcentinib in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.

Latest updates to the Bemcentinib in AML/MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to the study details, eligibility criteria, locations, or outcome measures were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now shows an updated revision tag (v3.4.1) replacing the previous v3.4.0; this is a minor metadata update and does not affect study details, locations, or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedUI changes add Show glossary and Hide glossary controls and update metadata with Last Update Submitted that Met QC Criteria and No FEAR Act Data, plus Revision: v3.4.0. The older label Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page update only changes the website revision label from v3.3.3 to v3.3.4; no study data or page content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page adds a Locations section with site names (Iowa, Texas, Carl-Neuberg-Str, Hamburg-Eppendorf, Theodor-Stern-Kai, Jonas Lies Vei) and removes several previous location entries, and the revision updates from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check91 days agoChange DetectedPublications section now notes that entries are auto-filled from PubMed, and the revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Bemcentinib in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.